Eywa's product pipeline has been built spanning complex formulations, high-volume products and limited competition products through organic development as well as strategic in-licensing in order to accelerate our portfolio build-up.
We have built a well-balanced portfolio based on our extensive experience in global pharmaceutical markets and understanding of the evolving market dynamics. Our portfolio consists of:
- Niche products with limited, or in some cases, no generic competition
- Products expected to go off-patent in the years to come
- High volume products
- Products with history of supply disruptions